CRM
59
-11
GS
78
2
ETR
52
3
F
58
2
DIS
72
2
HRL
38
3
GWW
65
3
ES
50
3
SIG
52
2
RF
63
2
STZ
49
2
PX
55
2
FIS
73
11
IFF
62
5
PG
43
2
HBAN
82
2
NKE
36
6
CSX
50
2
NEE
52
2
CNP
55
3
CRM
59
-11
GS
78
2
ETR
52
3
F
58
2
DIS
72
2
HRL
38
3
GWW
65
3
ES
50
3
SIG
52
2
RF
63
2
STZ
49
2
PX
55
2
FIS
73
11
IFF
62
5
PG
43
2
HBAN
82
2
NKE
36
6
CSX
50
2
NEE
52
2
CNP
55
3
Financhill
Back

NextCure, Inc. 10K Form

Sell
44

NXTC
NextCure, Inc.

Last Price:
$12.82
Seasonality Move:
2.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NXTC News And Ratings

See the #1 stock for the next 7 days that we like better than NXTC

NXTC Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-6.3M
Price / Cash Flow: 0
Annual Sales: $8.84
Price / Book: 1.45

Profitability

EPS (TTM): -19.87490
Net Income (TTM): $-58M
Gross Margin: $-2.9M
Return on Equity: -115.01%
Return on Assets: -88.78%

NextCure, Inc. Earnings Forecast

Key NextCure, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 2 years.

NextCure, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NXTC
CUSIP: 65343E
Website: nextcure.com

Debt

Debt-to-Equity Ratio: 0.2
Current Ratio: 2.97
Quick Ratio: 2.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NXTC Technical Analysis vs Fundamental Analysis

Sell
44
NextCure, Inc. (NXTC) is a Sell

Is NextCure, Inc. a Buy or a Sell?

  • NextCure, Inc. stock is rated a Sell
    The current NextCure, Inc. [NXTC] share price is $12.79. The Score for NXTC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.